Angio Suites Market Size

Angio Suites Market size was over USD 433.23 billion in 2024 and is poised to exceed USD 1.28 trillion by 2037, growing at over 8.7% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of angio suites is evaluated at USD 495.63 billion.

The growth of the angio suites market can be attributed to the increasing prevalence of cardiovascular and other chronic diseases. WHO reports that cardiovascular diseases (CVDs) account for the majority of deaths worldwide, with 17.9 million people estimated to have died from CVDs in 2019. The prevalence of chronic diseases in the United States is approximately 133 million, representing more than 40% of the total population. Approximately 157 million people were expected to have multiple conditions in 2020, with 81 million being diagnosed with multiple conditions. Angio suites are equipped with advanced imaging technologies, such as CT scanners and MRI machines, that are widely used to cardiovascular diagnostics and treatment.

In addition to these, factors that are believed to fuel the growth of market include increased funding, grants, and investments by public-private organizations in healthcare along with growing demand for minimally invasive surgeries (MIS).  A total of 10.6 million MIS encounters were recorded in 2016, 10.6 million in 2017, and 10.7 million in 2018, respectively. Furthermore, the percentage of encounters involving MIS procedures in 2016, 2017, and 2018 was 16.9%, 17.4%, and 18%. Angio suites market are equipped with imaging devices that allow surgeons to perform complex procedures with precision, thus reducing the risk of complications and allowing patients to recover more quickly. Additionally, they are cost-effective and can be used for a variety of procedures, making them an attractive option for hospitals. They are also used to perform minimally invasive surgeries, such as angioplasty and stenting, to improve blood flow in the affected areas.